Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Wall Street
Price Targets
YMAB Price Targets Summary
Y-mAbs Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
YMAB
is 21.86 USD
with a low forecast of 12.12 USD and a high forecast of 27.3 USD.
YMAB Last Price Targets
Y-mAbs Therapeutics Inc
The latest public price target was made on Apr 5, 2024 by
Etzer Darout
from
BMO Capital
,
who expects
YMAB
stock to
rise by 77%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Etzer Darout
BMO Capital
|
26
USD
Upside 77% |
3 weeks ago
Apr 5, 2024
|
BMO Capital on Y-mAbs Therapeutics (YMAB): 'Radiopharma Is Hot & SADA De-Risking Would Unlock Value'
StreetInsider
|
YMAB)to Outperform
Wedbush
|
13
USD
Downside 12% |
11 months ago
May 10, 2023
|
Analyst Upgrades Y-mAbs On Bullish Danyelza Sales Outlook, Improved Visibility
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is YMAB's stock price target?
Price Target
21.86
USD
According to Wall Street analysts, the average 1-year price target for
YMAB
is 21.86 USD
with a low forecast of 12.12 USD and a high forecast of 27.3 USD.
What is Y-mAbs Therapeutics Inc's Revenue forecast?
Projected CAGR
14%
The
compound annual growth rate
of Y-mAbs Therapeutics Inc's revenue for the next 3 years is
14%.
You don't have any saved screeners yet
